Literature DB >> 7531200

A novel role for E- and P-selectins: shape control of endothelial cell monolayers.

G Kaplanski1, C Farnarier, A M Benoliel, C Foa, S Kaplanski, P Bongrand.   

Abstract

The migration of neutrophils from blood vessels to peripheral tissues is a key step of inflammation. This requires the formation of transient gaps between endothelial cells with concomitant leucocyte squeezing through these narrow apertures and immediate restoration of endothelium continuity. It is currently considered that the main role of selectins is to mediate the initial contact between flowing leucocytes and endothelial cells. We show here that the binding of E- or P-selectins by specific antibodies induces a marked 'rounding up' of interleukin-1- or thrombin-activated human endothelial cells, respectively. Also, anti-E-selectin antibodies trigger a transient increase in cytosolic calcium involving intracellular calcium stores. No such effect is observed when von Willebrand factor or intercellular adhesion molecule 1 are similarly bound. Thus, in addition to promoting the initial interaction between activated endothelium and moving leucocytes, selectins might play a role in the induction of subsequent endothelial deformation, which would facilitate leucocyte arrest and transmigration towards peripheral tissues, and enhance the diffusion of soluble molecules between intravascular and peripheral compartments. Our results are consistent with this hypothesis and demonstrate a new property of endothelial selectins.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7531200     DOI: 10.1242/jcs.107.9.2449

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  18 in total

1.  "Stuck on sugars - how carbohydrates regulate cell adhesion, recognition, and signaling".

Authors:  Richard D Cummings
Journal:  Glycoconj J       Date:  2019-07-02       Impact factor: 2.916

2.  How cells tiptoe on adhesive surfaces before sticking.

Authors:  Anne Pierres; Anne-Marie Benoliel; Dominique Touchard; Pierre Bongrand
Journal:  Biophys J       Date:  2008-01-30       Impact factor: 4.033

Review 3.  The selectins: insights into selectin-induced intracellular signaling in leukocytes.

Authors:  E Crockett-Torabi; J C Fantone
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

Review 4.  The role of vitamin D in hepatic metastases from colorectal cancer.

Authors:  E Shaw; N Massaro; N T Brockton
Journal:  Clin Transl Oncol       Date:  2017-08-11       Impact factor: 3.405

Review 5.  Markers of tumor angiogenesis: clinical applications in prognosis and anti-angiogenic therapy.

Authors:  S B Fox; A L Harris
Journal:  Invest New Drugs       Date:  1997       Impact factor: 3.850

Review 6.  Pathogenesis of diabetic cerebral vascular disease complication.

Authors:  Ren-Shi Xu
Journal:  World J Diabetes       Date:  2015-02-15

7.  Detection of differentially expressed glycogenes in trabecular meshwork of eyes with primary open-angle glaucoma.

Authors:  Shiri Diskin; Janardan Kumar; Zhiyi Cao; Joel S Schuman; Tim Gilmartin; Steven R Head; Noorjahan Panjwani
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-04       Impact factor: 4.799

8.  Serum soluble E-selectin and NT-proBNP levels additively predict mortality in diabetic patients with chronic heart failure.

Authors:  Judit Czúcz; László Cervenak; Zsolt Förhécz; Tímea Gombos; Zoltán Pozsonyi; Jan Kunde; István Karádi; Lívia Jánoskuti; Zoltán Prohászka
Journal:  Clin Res Cardiol       Date:  2011-02-11       Impact factor: 5.460

Review 9.  Targeting selectins and selectin ligands in inflammation and cancer.

Authors:  Steven R Barthel; Jacyln D Gavino; Leyla Descheny; Charles J Dimitroff
Journal:  Expert Opin Ther Targets       Date:  2007-11       Impact factor: 6.902

10.  Effect of tumour necrosis factor-alpha receptor 1 genetic deletion on carrageenan-induced acute inflammation: a comparison with etanercept.

Authors:  E Mazzon; E Esposito; R Di Paola; C Muià; C Crisafulli; T Genovese; R Caminiti; R Meli; P Bramanti; S Cuzzocrea
Journal:  Clin Exp Immunol       Date:  2008-05-26       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.